In Vivo Gene Editing Therapies Offer Root-Cause Treatment for Genetic Diseases, but Efficient and Precise Liver-Targeted Delivery Remains a Critical Hurdle for Clinical Translation. Lipid Nanoparticles (LNPs), as the Mainstream Non-Viral Vector, Have Made Functionalization a Core Strategy for Enhancing Targeting Efficiency. Xiamen Sinopeg Biotech Co., Ltd. (Sinopeg) is proud to introduce its independently innovated structure,GalNAc-PEG-DTA-5-2K. This liver-targeting functional PEG lipid, specifically designed for LNP systems, aims to provide gene editing and siRNA drug developers with a high-performance excipient option featuring a clear IP profile. It is set to empower the advancement of liver-targeted therapeutic pipelines. I. Delivery Challenges for Liver-Targeted Gene Editing The in vivo application of gene editing therapies hinges on the safe and precise delivery of the CRISPR system (editor mRNA and guide RNA) to target cells. LNPs have become a recognized in vivo delivery platform, owing to their excellent encapsulation and protection capabilities, low immunogenicity, and scalability for manufacturing. However, after intravenous administration, conventional LNPs are largely cleared by liver immune cells or degraded in circulation, with a limited fraction reaching hepatocytes. This restricts therapeutic efficacy and may increase off-target risks. Thus, endowing LNPs with active liver-targeting capabilities is an inevitable direction for technological advancement. Among targeting strategies, the N-acetylgalactosamine (GalNAc) ligand stands out as a well-established and extensively validated liver-targeting approach. Its receptor, the asialoglycoprotein receptor (ASGPR), is highly expressed on the surface of hepatocytes and is not found at significant levels in other tissues. This makes the GalNAc-ASGPR pathway a highly efficient and specific natural targeting mechanism. GalNAc ligands can specifically bind to ASGPR, facilitating efficient cellular uptake via receptor-mediated endocytosis. Integrating this strategy into LNP systems offers a new design dimension for the hepatic delivery of gene editing drugs. II. Industry Trend: GalNAc-PEG Lipids Emerge as a Consensus Direction for Liver-Targeted LNPs In the field ofin vivogene editing, cutting-edge research from both international and domestic fronts is converging on the GalNAc-PEG lipid technology pathway. U.S.-based Verve Therapeutics, in its second-generationin vivobase editing therapy, has incorporated GalNAc targeting ligands into its LNP delivery system, modifying the LNP surface with GalNAc-containing PEG lipids. This upgrade aims to enhance liver targeting, increase drug concentration within hepatocytes, thereby achieving effective editing at lower doses and improving drug tolerability and safety. Drawing on clinical experience from its first-generation product, Verve has made a clear targeted enhancement to its delivery vehicle, reflecting that GalNAc-LNPs have become a technological...

Nat Commun. 2025 May 20;16(1):4700. doi: 10.1038/s41467-025-60040-9. Freezing induced incorporation of betaine in lipid nanoparticles enhances mRNA delivery Abstract Lipid nanoparticles (LNPs) are key non-viral carriers for mRNA vaccines and therapeutics, but the inherent instability of mRNA necessitates sub-zero storage with cryoprotectants (CPAs) to prevent freeze-induced LNP aggregation and compromised mRNA delivery. Here we show that ice formation during freezing concentrates CPAs with LNPs in the remaining liquid-a phenomenon known as freeze concentration. This creates a steep concentration gradient of CPAs across the lipid membrane that drives passive CPAs diffusion into LNPs. By leveraging this process, we developed betaine-based CPAs that both preserve the stability of LNP and enter LNP during freeze-thaw. The incorporated betaine enhances endosomal escape and boosts mRNA delivery of LNP. In female mice, betaine-loaded LNPs elicit stronger humoral and cellular immune responses, providing dose-sparing advantages. These findings highlight freeze concentration as a promising LNP formulation strategy and underscore the role of CPA as active modulators of LNP structure and function. Product: lipids for LNP

Mol Ther Nucleic Acids. 2025 Feb 12;36(2):102485. doi: 10.1016/j.omtn.2025.102485. eCollection 2025 Jun 10. Enhancing mRNA translation efficiency by introducing sequence optimized AU-rich elements in 3' UTR via HuR anchorage Abstract mRNA technology holds immense promise as an innovative therapeutic approach with applications spanning infectious disease vaccines, cancer immunotherapy, protein replacement, and gene editing. However, practical use of mRNA has been hindered by challenges such as low cellular stability and transient protein expression. For addressing these, we propose a novel strategy to optimize mRNA sequences, particularly in the untranslated region, by inserting adenylate/uridylate-rich elements (AU-rich elements) to enhance stability and protein expression. Our investigation revealed that integrating AU-rich elements between the open reading frame (ORF) and the 3' untranslated region (3' UTR) significantly enhances RNA stability compared with other insertion sites. We identified cytoplasmic Human antigen R (HuR) as an essential RNA-binding protein responsible for promoting mRNA stability and translation, confirmed through HuR knockdown experiments and pull-down assays between AU-rich elements and HuR. Through rational design, we optimized the sequence of natural AU-rich elements and identified the essential "AUUUA" element, which, with certain repeats, can increase protein expression up to 5-fold. To demonstrate the universality of AU-rich element sequences in enhancing mRNA translation, we switched the coding proteins from luciferase to EGFP, mCherry, and ovalbumin (OVA), finding that both natural and engineered AU-rich element sequences amplify the expression of these proteins. In conclusion, leveraging the functionalities of RNA-binding proteins and the natural regulation of RNA stability in the untranslated region represents a novel strategy to enhance mRNA pharmacokinetics in the cytoplasm, expanding the potential applications of mRNA in therapeutic drugs. Keywords: 3′ UTR rational design; AU-rich elements; HuR; MT: Oligonucleotides: Therapies and Applications; RNA stability; RNA-binding proteins; mRNA vaccines; sequence optimization. Product: lipids for LNP

ACS Nano. 2025 Dec 16;19(49):41803-41815. doi: 10.1021/acsnano.5c15619. Epub 2025 Dec 4. Engineering of Metal-Organic Networks as Band-Aid for the Repair of Osteoporotic Bone Fractures Abstract The treatment of osteoporotic bone fractures remains a critical challenge due to the dysregulated bone remodeling microenvironment characterized by excessive osteoclastic resorption, impaired osteogenic differentiation, angiogenic dysfunction, and chronic inflammation. In this work, we engineered a metal-organic network as a bone repair "band-aid" by integrating poly(ethylene glycol)-alendronate (PEG-ALN) conjugates with bioactive epigallocatechin gallate (EGCG), zinc, and calcium ions into a multifunctional scaffold. This design leverages the synergistic effects of anti-inflammatory and antioxidant properties of EGCG with the balancing osteogenic and osteoclastic functions of ALN, zinc, and calcium ions. In vitro studies demonstrated that the band-aid significantly enhanced the proliferation and differentiation of osteoblasts while promoting endothelial cell migration and tubule formation, indicating the robust osteogenic and angiogenic potential. In vivo evaluations in an osteoporotic bone fracture model revealed accelerated bone regeneration and improved microvascularization while maintaining a balanced immune response to prevent chronic inflammation. Mechanistically, the band-aid modulated macrophage polarization toward a pro-regenerative M2 phenotype and suppressed excessive osteoclast activity, thereby restoring the osteogenic-osteoclastic equilibrium. This study not only provides a therapeutic implant for osteoporotic bone repair but also proposes a strategy for designing immunomodulatory scaffolds that target the pathological bone microenvironment. Keywords: bone repair; metal−organic networks; osteoporosis; polyphenols; tissue engineering. Product: 8-arm-PEG-NHS

J Phys Chem Lett. 2025 Apr 17;16(15):3874-3878. doi: 10.1021/acs.jpclett.5c00825. Epub 2025 Apr 10. Double-Helix Duality: Rods Bow, Toroids Wow in the Nuclease Arena Abstract Utilizing polyion complexation, the formation of rod-like DNA condensates is driven by the intrinsic rigidity of supramolecular plasmid DNA. Upon interaction with polycationic block copolymers of poly(ethylene glycol)-polylysine (PEG-PLys), these macromolecules undergo a regular self-folding process, during which double-stranded DNA (dsDNA) transitions into single-stranded DNA (ssDNA) at the kinked junctions. Our investigations, employing transmission electron microscopy (TEM), unprecedentedly reveal the absence of a PEG coating at these critical junctions, rendering them susceptible to nuclease degradation. This finding underscores the critical necessity for comprehensive PEG encapsulation in the engineering of robust gene delivery constructs. In stark contrast to the anisotropic rod-like condensates, our novel isotropic toroidal DNA condensates, characterized by comprehensive PEG shielding and a self-spooling mechanism that preserves dsDNA integrity, exhibit a marked enhancement in enzymatic stability (nearly 30-fold greater). Their favorable condensation process also confers superior transcriptional potential, positioning these toroidal condensates as promising platforms for the next generation of gene delivery systems. Product: mPEG-NH2

Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2406434121. doi: 10.1073/pnas.2406434121. Epub 2024 Oct 22. CXCL13 promotes broad immune responses induced by circular RNA vaccines Abstract Antibody responses induced by current vaccines for influenza and SARS-CoV-2 often lack robust cross-reactivity. As hubs where diverse immune cells converge and interact, the alterations in the immune microenvironment within lymph nodes (LNs) are intricately linked to immune responses. Herein, we designed a lipid nanoparticle (LNP) loaded with circular RNA (circRNA) and targeted to LNs, in which CXCL13 was directly integrated into antigen-encoding circRNA strands. We demonstrated that CXCL13 alters the transcriptomic profiles of LNs, especially the upregulation of IL-21 and IL-4. Meanwhile, CXCL13 promotes the formation of germinal center and elicits robust antigen-specific T cell responses. With the codelivery of CXCL13 and the antigen, CXCL13 enhances cross-reactive antibodies against influenza virus and SARS-CoV-2, achieving protection against both homologous and heterologous influenza virus challenges in a mouse model. Notably, the targeted modification of LNP surfaces with antibodies helps address some of the challenges associated with lyophilized LNP vaccines, which is crucial for the long-term storage of LNP-circRNA vaccines. Overall, the circRNA-based antigen-CXCL13 coexpression system developed herein provides a simple and robust platform that enhances the magnitude and breadth of antibody responses against multiple viral glycoproteins, highlighting the potential utility of CXCL13 in inducing broad immune responses. Keywords: CXCL13; SARS-CoV-2; broadly cross-reactive antibodies; circRNA vaccine; influenza virus. Product: SM-102

Adv Healthc Mater. 2025 Mar;14(6):e2403865. doi: 10.1002/adhm.202403865. Epub 2025 Jan 2. Coacervate-Derived Assembly of Poly(ethylene glycol) Nanoparticles for Combinational Tumor Therapy Abstract Coacervates have garnered significant attention as potential drug carriers. However, the instability resulting from their intrinsic membrane-free nature restricts the application of coacervates in drug delivery. Herein, the engineering of poly(ethylene glycol) nanoparticles (PEG NPs) is reported using coacervates composed of PEG and polyphenols as the templates, where PEG is subsequently cross-linked based on different chemistries (e.g., thiol-disulfide exchange, click chemistry, and Schiff base reaction). The reported assembly strategy avoids the template removal process and the resultant PEG NPs exhibit excellent stability in the physiological environment compared to coacervates. The presence of polyphenols in PEG NPs enables the loading of various cargos including metal ions (i.e., Ru, Gd, Mn, Fe) and drug molecules (i.e., doxorubicin), which demonstrates their promise in magnetic resonance imaging and combinational tumor therapy. This work provides a promising strategy to promote the development of coacervate-derived NPs as a drug delivery system for biomedical applications. Keywords: coacervates; drug delivery; nanoparticles; poly(ethylene glycol); self‐assembly. Product: 8-arm PEG-NH2HCl (HG)

Biomaterials. 2026 Feb:325:123568. doi: 10.1016/j.biomaterials.2025.123568. Epub 2025 Jul 19. Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer Abstract Triple-negative breast cancer (TNBC) poses significant therapeutic challenges due to its metabolic plasticity and immunosuppressive microenvironment. In this study, we present a sequential drug release hydrogel system (SeqGel) that reprograms tumor metabolism and modulates the immune landscape to suppress TNBC growth and metastasis. The poly(ethylene glycol)-based injectable hydrogel system could enable tunable biodegradation within 48 h to ensure repeated peritumoral administration and localized controlled drug release. Specifically, water-soluble small molecular dichloroacetate is rapidly released to redirect tumor cell metabolism from glycolysis to oxidative phosphorylation, thereby reducing lactic acid accumulation, restricting glucose uptake, and enhancing the susceptibility of cancer cells to mitochondrial damage. This is followed by the sustained release of pH-sensitive, copper complex-loaded polymeric nanoparticles PED@tCu, which facilitates efficient intracellular delivery and targeted mitochondrial localization, specifically impairing the function of complex II. Mechanistically, the ordered metabolic intervention enhances antitumor immunity by activating the AMPK pathway, promoting PD-L1 degradation, and upregulating MHC I to improve antigen presentation. In 4T1 subcutaneous tumor models, SeqGel effectively suppressed tumor growth and markedly reduced lung and lymph node metastases by promoting CD8+ T cell infiltration and depleting regulatory T cells. This study establishes a paradigm for metabolic-immune synergy, offering a promising strategy for targeting aggressive cancers through chrono-metabolic immunotherapy. Keywords: Hydrogel; Immunogenic cuproptosis; Immunotherapy; Metabolic reprogramming; Sequential drug release. Product: 4-arm PEG-SG